Clinical Trial

A Study Of Effect Of Secretin For In Injection (Chirostim) On Pancreatic Fluid Composition In Healthy Subjects

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The purpose of this study is to collect pancreas fluid from the duodenum using the endoscopic pancreas function collection method in healthy participants after pancreatic stimulation with human secretin.
Protocol Amendment History 3 changes
critical Recruitment opened 2026-04-29
notable Primary completion pushed: 2027-01 -> 2027-03 2026-04-29
minor Completion pushed: 2028-01 -> 2028-03 2026-04-29
Trial Details
NCT Number NCT07285863
Lead Sponsor Mayo Clinic
Collaborators: ChiRhoClin, Inc.
Conditions Exocrine Pancreatic Insufficiency, Chronic Pancreatitis
Enrollment 24 participants
Start Date 2026-03-11
Primary Completion 2027-03 (estimated)
Study Completion 2028-03 (estimated)
Updated on ClinicalTrials.gov 2026-07-07